Articles
A new Korean biotech company seeks to leverage the multi-faceted therapeutic benefit of FK506 to create a newer and safer hair growth drug. As we are gratified to see completely new approaches emerge in the hair growth space, we should also value the strategy of creating new and improved iterations of older hair growth drugs…
Read More
Epibiotech continues to announce important milestones and progress leading up to a Phase 1 clinical trial for its cell therapy in AGA. Innovative Drug Discovery For Hair-Loss Therapy Symposium Earlier this year in June, Epibiotech co-hosted a hair loss research conference in South Korea with Yonsei University’s Pharmaceutical Research Institute. The meeting, titled “Innovative Drug…
Read More
The long awaited phase II results from Kintor’s KX-826 (pyrilutamide) study in males with androgenetic alopecia have surfaced online. KX-826 Phase 2 Results Presentation Several months ago in May, the 28th Annual Meeting of the Chinese Society of Dermatology was postponed from June to the beginning of September 2022. This was the acclaimed conference where…
Read More
A new reality tv series about people seeking solutions for hair loss, alopecia, and other dermatology-related conditions is coming soon to the TLC channel. Reality TV Hair Loss Show Much in the spirit of the “Dr. Pimple Popper” show, the TLC television network is rolling out a new medically-focused reality show featuring three female hair…
Read More
A new drug aimed at the treatment of androgenetic alopecia is entering a phase 1 clinical trial imminently as of August 2022. CU-40101 Phase 1 Clinical Trial Cutia Therapeutics is the latest biotechnology company to emerge from behind the scenes and enter the global race for new androgenetic alopecia therapies. Its candidate molecule CU-40101 is…
Read More
An FDA approved drug is currently being researched for its repurposed potentials in wound regeneration and hair regrowth. 4-Aminopyridine is a prescription medicine used for the treatment of multiple sclerosis. It’s marketed under the brand name Ampyra and is classified as a potassium channel blocker. This compound, also known as 4-AP or dalfampridine, was the…
Read More
This article contains a wealth of information on hair transplant surgery, photographic examples of hair transplant results, and practical guidance on how to make the right decisions when considering a hair transplant surgeon. Hair Transplant Surgery – 2022 Hair transplants have become an increasingly popular topic over the past several years as multiple celebrities, sports…
Read More
Several new companies are developing exosome therapies to treat hair loss. Unlike previous iterations of exosomes treatments, these therapies will undergo clinical trials within the FDA approval process. Exosomes And Hair Growth Around two years ago, exosomes became the latest hot topic in hair restoration and hair loss treatments. Various hair transplant surgeons and dermatologists…
Read More
Moogene Medi of Korea shares an update on their topical anti-DHT therapies utilizing microbubble delivery and ultrasound technology with limited systemic exposure. HUTERA Hair Loss Treatment In November 2020, Follicle Thought introduced Moogene Medi as the first company officially working on a CRISPR gene editing therapy for hair loss. Over a year and a half…
Read More
A world class training course on hair follicle science and discovery will be held in Münster, Germany in June 2022. 2nd Hair Biology & Translational Research in a Nutshell The world’s leading contract research organization for skin and hair follicle sciences, Monasterium Laboratory, is hosting a top-tier educational course June 9 – 10 2022 in Münster,…
Read More